Upsher-Smith is offering Pitavastatin tablets in 1 mg, 2 mg and 4 mg strengths, which is the generic of Livalo.
Livalo is a statin medication that can help improve overall cholesterol levels.
Pitavastatin tablets have a market value of $302 million for the 12 months ending August 2023, per IQVIA.
Sawai USA holds the ANDA for Pitavastatin tablets. This marks Sawai’s first Paragraph IV product to be launched in the United States. Upsher-Smith will distribute the product in the United States.